Study of Fish Oil to Reduce ALT Levels in Adolescents

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Non-alcoholic Fatty Liver DiseaseFatty Liver
Interventions
DRUG

Omega-3-acid ethyl esters

Participants will receive 2 capsules of 1 gram of fish oil with meals twice a day for a period of six months (including a ramp up period of three weeks)

DRUG

Placebo

Participants will receive 2 capsules of 1 gram of placebo with meals twice a day for a period of six months (including a ramp up period of three weeks)

Trial Locations (1)

02118

Boston University Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Boston University

OTHER

NCT00694746 - Study of Fish Oil to Reduce ALT Levels in Adolescents | Biotech Hunter | Biotech Hunter